FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3138327475> ?p ?o ?g. }

• W3138327475 endingPage "478.e5" @default.
• W3138327475 startingPage "478.e1" @default.
• W3138327475 abstract "Allogeneic stem cell transplantation from haploidentical donor using post-transplantation cyclophosphamide has been used to cure hematological diseases. Because of slow immunological reconstitution, there is an increased incidence of viral infection. The aim of our study was to prospectively evaluate the efficacy and the feasibility of a CD45RA+ depleted donor lymphocytes infusion (DLI) in terms of reduction of viral infection early after haploidentical transplantation. This a prospective single-center study. We enrolled 23 patients, of whom 19 were evaluable. Graft-versus-host disease (GVHD) prophylaxis was the same for all patients. The primary endpoint was 100-day cumulative incidence of viral infections. The primary endpoint was met, because the 100-day cumulative incidence of viral infection was 32%. The median time from transplantation to first CD45RA+ depleted DLI was 55 days (range, 46-63). 28% of patients had cytomegalovirus reactivation, no patients reactivated human herpesvirus-6; 1 patient developed BK virus related hemorrhagic cystitis. Most of the patients received the planned 3 infusions. Only 1 patient had development of grade 2 acute GVHD, and 2 patients had moderate chronic GVHD. All evaluable patients were off immunosuppressive therapy at last follow-up. The median follow-up was 12 months (range, 3-23), the 1-year overall survival and progression-free survival were 79% and 75%, respectively; the 100-day and 1-year non-relapse mortality were 5% and 12%, respectively. CD45RA+ depleted DLI are feasible in patients treated with haploidentical transplantation. The toxic profile is good with a low risk for development of both acute and chronic GVHD." @default.
• W3138327475 created "2021-03-29" @default.
• W3138327475 creator A5013760932 @default.
• W3138327475 creator A5021041745 @default.
• W3138327475 creator A5021060422 @default.
• W3138327475 creator A5023596964 @default.
• W3138327475 creator A5026671016 @default.
• W3138327475 creator A5028972598 @default.
• W3138327475 creator A5039359872 @default.
• W3138327475 creator A5043616742 @default.
• W3138327475 creator A5045159459 @default.
• W3138327475 creator A5045261121 @default.
• W3138327475 creator A5053059435 @default.
• W3138327475 creator A5074673843 @default.
• W3138327475 creator A5078056183 @default.
• W3138327475 creator A5080298171 @default.
• W3138327475 creator A5080950952 @default.
• W3138327475 creator A5082515771 @default.
• W3138327475 creator A5084668012 @default.
• W3138327475 creator A5086816665 @default.
• W3138327475 date "2021-06-01" @default.
• W3138327475 modified "2023-10-10" @default.
• W3138327475 title "Feasibility and Efficacy of CD45RA+ Depleted Donor Lymphocytes Infusion After Haploidentical Transplantation With Post-Transplantation Cyclophosphamide in Patients With Hematological Malignancies" @default.
• W3138327475 cites W1511201911 @default.
• W3138327475 cites W1603504083 @default.
• W3138327475 cites W1913133353 @default.
• W3138327475 cites W1971984984 @default.
• W3138327475 cites W1981542309 @default.
• W3138327475 cites W1988718803 @default.
• W3138327475 cites W2020725971 @default.
• W3138327475 cites W2034877897 @default.
• W3138327475 cites W2039334806 @default.
• W3138327475 cites W2043579068 @default.
• W3138327475 cites W2067480394 @default.
• W3138327475 cites W2068699102 @default.
• W3138327475 cites W2073493139 @default.
• W3138327475 cites W2075009488 @default.
• W3138327475 cites W2116483603 @default.
• W3138327475 cites W2134077221 @default.
• W3138327475 cites W2148233118 @default.
• W3138327475 cites W2148995443 @default.
• W3138327475 cites W2152041770 @default.
• W3138327475 cites W2307073326 @default.
• W3138327475 cites W2412214702 @default.
• W3138327475 cites W2576236969 @default.
• W3138327475 cites W2618073389 @default.
• W3138327475 cites W2745549673 @default.
• W3138327475 cites W2771598353 @default.
• W3138327475 cites W2911845849 @default.
• W3138327475 cites W2914763076 @default.
• W3138327475 cites W3000638281 @default.
• W3138327475 cites W3023222964 @default.
• W3138327475 cites W3025423143 @default.
• W3138327475 cites W3040015203 @default.
• W3138327475 cites W3110100866 @default.
• W3138327475 cites W4254477139 @default.
• W3138327475 doi "https://doi.org/10.1016/j.jtct.2021.03.010" @default.
• W3138327475 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33819481" @default.
• W3138327475 hasPublicationYear "2021" @default.
• W3138327475 type Work @default.
• W3138327475 sameAs 3138327475 @default.
• W3138327475 citedByCount "7" @default.
• W3138327475 countsByYear W31383274752021 @default.
• W3138327475 countsByYear W31383274752022 @default.
• W3138327475 countsByYear W31383274752023 @default.
• W3138327475 crossrefType "journal-article" @default.
• W3138327475 hasAuthorship W3138327475A5013760932 @default.
• W3138327475 hasAuthorship W3138327475A5021041745 @default.
• W3138327475 hasAuthorship W3138327475A5021060422 @default.
• W3138327475 hasAuthorship W3138327475A5023596964 @default.
• W3138327475 hasAuthorship W3138327475A5026671016 @default.
• W3138327475 hasAuthorship W3138327475A5028972598 @default.
• W3138327475 hasAuthorship W3138327475A5039359872 @default.
• W3138327475 hasAuthorship W3138327475A5043616742 @default.
• W3138327475 hasAuthorship W3138327475A5045159459 @default.
• W3138327475 hasAuthorship W3138327475A5045261121 @default.
• W3138327475 hasAuthorship W3138327475A5053059435 @default.
• W3138327475 hasAuthorship W3138327475A5074673843 @default.
• W3138327475 hasAuthorship W3138327475A5078056183 @default.
• W3138327475 hasAuthorship W3138327475A5080298171 @default.
• W3138327475 hasAuthorship W3138327475A5080950952 @default.
• W3138327475 hasAuthorship W3138327475A5082515771 @default.
• W3138327475 hasAuthorship W3138327475A5084668012 @default.
• W3138327475 hasAuthorship W3138327475A5086816665 @default.
• W3138327475 hasBestOaLocation W31383274751 @default.
• W3138327475 hasConcept C120665830 @default.
• W3138327475 hasConcept C121332964 @default.
• W3138327475 hasConcept C126322002 @default.
• W3138327475 hasConcept C141071460 @default.
• W3138327475 hasConcept C203092338 @default.
• W3138327475 hasConcept C2776694085 @default.
• W3138327475 hasConcept C2776755627 @default.
• W3138327475 hasConcept C2777408962 @default.
• W3138327475 hasConcept C2777600175 @default.
• W3138327475 hasConcept C2779972918 @default.
• W3138327475 hasConcept C2911091166 @default.
• W3138327475 hasConcept C535046627 @default.
• W3138327475 hasConcept C61511704 @default.

• next